The U.S. Food and Drug Administration (FDA) has approved Lynparza (olaparib) for a difficult-to-treat form of metastatic breast cancer. Patients with BRCA-mutated, HER2-negative breast cancer who have previously been treated with chemotherapy are now approved to be treated with Lynparza. The FDA’s approval is based on data showing that Lynparza — developed by AstraZeneca working together with Merck (known…
Breast Self-Awareness is not just checking your breast for a lump. It’s… Know Your Risk Your doctor has new tools to help identify women at high risk for breast cancer. Identify your risk factors for breast cancer and discuss them with your doctor: Increasing age Having a mother, sister, or daughter…
We always like to inform all of you about the risk of getting breast cancer in specifically females: Genetics: When your family members have a history of cancer like your mother, aunt, and/or grandmother especially when it’s detected at a younger age. The chances of you getting cancer is higher.…
